Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. 8-K Event Other events
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 3 Insider Initial Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 8-K Event Other events
  9. 8-K Event Material agreement · Unregistered share sale
  10. CT ORDER Other Confidential Order
  11. 8-K Event Agreement ended
  12. 4 Open-market sale Chief Scientific Officer sold 17,535 shares at $15.02 ($263,300)
  13. SC 13G Stake Amended Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4 Open-market sale Chief Scientific Officer sold 600 shares at $15.00 ($9,000)

Page 32 of 47 · 923 filings